Concepedia

C. Allison Stewart

CA

32

Publications

3.1K

Citations

23

H-Index

1936

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Baylor College of Medicine

University of Campania "Luigi Vanvitelli"

The University of Texas Southwestern Medical Center

University of Houston

C. Allison Stewart is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cell biology, and tumor biology.

ORCID

Top concepts

Publications per year

1936–2024

32

Publications

32

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

Carl M. Gay, C. Allison Stewart, Elizabeth M. Park et al. · Cancer Cell · 2021 · 864 citations · Full text

, , +11

Single-cell analyses reveal increased intratumoral heterogeneity after the onset of therapy resistance in small-cell lung cancer

C. Allison Stewart, Carl M. Gay, Yuanxin Xi et al. · Nature Cancer · 2020 · 357 citations · Full text

, , +10

Dynamic variations in epithelial-to-mesenchymal transition (EMT), ATM, and SLFN11 govern response to PARP inhibitors and cisplatin in small cell lung cancer

C. Allison Stewart, Pan Tong, Robert J. Cardnell et al. · Oncotarget · 2017 · 221 citations · Full text

, , +17

CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib

Triparna Sen, Pan Tong, C. Allison Stewart et al. · Cancer Research · 2017 · 189 citations

STING Pathway Expression Identifies NSCLC With an Immune-Responsive Phenotype

Carminia Maria Della Corte, Triparna Sen, Carl M. Gay et al. · Journal of Thoracic Oncology · 2020 · 188 citations · Full text

, , +5

Rows per page

1–5 of 32